| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Zibotentan | GDSC1000 | pan-cancer | AAC | 0.0006 | 1 |
| mRNA | piperlongumine | CTRPv2 | pan-cancer | AAC | 0.00056 | 1 |
| mRNA | tamatinib | CTRPv2 | pan-cancer | AAC | 0.00051 | 1 |
| mRNA | carboplatin:UNC0638 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.00046 | 1 |
| mRNA | CP466722 | GDSC1000 | pan-cancer | AAC | 0.00027 | 1 |
| mRNA | Doxorubicin | CTRPv2 | pan-cancer | AAC | -0.00027 | 1 |
| mRNA | BRD-K66453893 | CTRPv2 | pan-cancer | AAC | -0.00028 | 1 |
| mRNA | ruxolitinib | GDSC1000 | pan-cancer | AAC | -0.00027 | 1 |
| mRNA | C6-ceramide | CTRPv2 | pan-cancer | AAC | -0.00026 | 1 |
| mRNA | GSK1059615 | CTRPv2 | pan-cancer | AAC | 0.00031 | 1 |